Schedule 13G ownership disclosure

ROYALTY PHARMA PLC- CL A

CLASS A COMMON STOCK · CUSIP: G7709Q104

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • FMR LLC

    Shares: 26,309,327.33 · Class: 5.9%

  • Abigail P. Johnson

    Shares: 26,309,327.33 · Class: 5.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000315066-25-000887
Form type
SCHEDULE 13G/A
Filer
FMR LLC
CIK
CIK 315066
Filed
Feb 12, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub